一个罕见的活化PI3K三角综合征 (APDS) 病例报告:诊断陷
Mohamad Qazreen Ahmad Shawaludin1,2, Zarina Thasneem Zainudeen3, Fahisham Taib1,2
1Department of Paediatrics, School of Medical Sciences, Universiti Sains Malaysia, Jalan Perempuan Zainab II, Kota Bahru, Kelantan, 16150, Malaysia.
BMC pediatrics
|November 3, 2025
概括
活性PI3Kδ综合征 (APDS) 的诊断是具有挑战性的,因为重叠的症状. 早期基因检测对于识别APDS和为这种罕见的免疫缺陷提供及时,有针对性的治疗至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
- 罕见疾病 罕见疾病
背景情况:
- 激活PI3Kδ综合征 (APDS) 是一种罕见的免疫遗传错误,具有不同的临床表现,包括感染,淋巴增殖和自身免疫.
- 在PI3Kδ途径的突变导致APDS,导致功能获取 (APDS1) 或功能丧失 (APDS2) 现型.
- 恶性病,特别是淋巴瘤,是一种严重的并发症,APDS经常被误诊为综合免疫缺陷.
研究的目的:
- 突出与APDS相关的诊断挑战.
- 强调早期基因检测在诊断APDS中的重要性.
- 讨论目前和潜在的APDS管理策略.
主要方法:
- 一个12岁男孩的病例报告,患有复发性感染和淋巴腺病.
- 最初的免疫学评估表明结合性免疫缺陷.
- 基因检测发现了PIK3CD突变,证实了APDS1.
主要成果:
- 该患者出现了复发性呼吸道和耳部感染,淋巴腺病变,肝炎,肝缩和血小板狭窄症.
- 尽管最初的诊断错误,但基因调查证实了APDS1.1.
- 患者开始接受免疫球蛋白替代疗法,并对进一步治疗进行评估.
结论:
- 在APDS的诊断延迟可能源于重叠的临床特征和外部因素,如成本和父母的决定.
- 早期遗传测试对于准确的APDS诊断和及时管理至关重要.
- 适当的管理包括免疫抑制疗法,向治疗和潜在的造血干细胞移植.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.5K
08:46A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
Published on: March 7, 2017
17.4K
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
The JAK-STAT Signaling Pathway
11.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.9K
